*	OR T3 T2 T1
R1	Has_qualifier Arg1:T4 Arg2:T3	
*	OR T6 T7
*	OR T8 T10 T9
R2	Has_qualifier Arg1:T8 Arg2:T11	
R3	AND Arg1:T6 Arg2:T8	
*	OR T15 T16
R4	AND Arg1:T14 Arg2:T15	
*	OR T21 T22 T23
R5	Subsumes Arg1:T19 Arg2:T21	
R6	Has_qualifier Arg1:T20 Arg2:T19	
R7	Has_index Arg1:T25 Arg2:T26	
R8	Has_temporal Arg1:T19 Arg2:T25	
*	OR T28 T29 T27
R9	Has_index Arg1:T30 Arg2:T31	
R10	Has_temporal Arg1:T28 Arg2:T30	
R11	Has_index Arg1:T35 Arg2:T36	
*	OR T33 T34
R12	Has_temporal Arg1:T33 Arg2:T35	
R13	Has_index Arg1:T41 Arg2:T42	
*	OR T38 T39
R14	Has_qualifier Arg1:T40 Arg2:T38	
R15	Has_temporal Arg1:T40 Arg2:T41	
*	OR T45 T47 T48
R16	Has_temporal Arg1:T45 Arg2:T46	
R17	Has_multiplier Arg1:T50 Arg2:T52	
R18	Has_index Arg1:T53 Arg2:T54	
R20	Has_index Arg1:T55 Arg2:T56	
*	OR T53 T55
R19	Has_temporal Arg1:T50 Arg2:T53	
R21	Has_index Arg1:T59 Arg2:T60	
R22	Has_temporal Arg1:T58 Arg2:T59	
R23	Has_qualifier Arg1:T58 Arg2:T61	
R24	Has_temporal Arg1:T64 Arg2:T63	
R25	Has_index Arg1:T66 Arg2:T67	
R26	Has_temporal Arg1:T65 Arg2:T66	
R27	Has_index Arg1:T70 Arg2:T71	
R28	Has_value Arg1:T68 Arg2:T69	
R29	Has_temporal Arg1:T68 Arg2:T70	
R30	Has_value Arg1:T72 Arg2:T73	
R31	Has_multiplier Arg1:T75 Arg2:T74	
R32	AND Arg1:T75 Arg2:T72	
R33	Has_index Arg1:T78 Arg2:T79	
R34	Has_multiplier Arg1:T76 Arg2:T77	
R35	Has_temporal Arg1:T76 Arg2:T78	
*	OR T75 T76
R36	Has_temporal Arg1:T81 Arg2:T80	
R37	Has_temporal Arg1:T81 Arg2:T82	
R38	Has_index Arg1:T82 Arg2:T83	
*	OR T84 T85
*	OR T87 T88
R39	Has_qualifier Arg1:T84 Arg2:T87	
R40	AND Arg1:T81 Arg2:T84	
R41	Has_temporal Arg1:T91 Arg2:T90	
R42	Has_value Arg1:T92 Arg2:T93	
R43	AND Arg1:T91 Arg2:T92	
R44	AND Arg1:T94 Arg2:T95	
*	OR T91 T94
R45	multi Arg1:T99 Arg2:T100	
*	OR T97 T98
R46	Has_qualifier Arg1:T97 Arg2:T99	
*	OR T102 T103
R47	Has_mood Arg1:T108 Arg2:T107	
*	OR T106 T108
R48	multi Arg1:T106 Arg2:T110	
R49	Has_mood Arg1:T110 Arg2:T109	
*	OR T113 T114
*	OR T115 T116
*	OR T111 T112
R50	Has_qualifier Arg1:T113 Arg2:T111	
R51	Has_temporal Arg1:T113 Arg2:T115	
*	OR T122 T121
R52	Has_context Arg1:T122 Arg2:T120	
R53	Has_qualifier Arg1:T125 Arg2:T124	
*	OR T126 T127
R54	Has_temporal Arg1:T126 Arg2:T128	
T1	Qualifier 25 37	uncontrolled
T2	Qualifier 13 21	unstable
T3	Qualifier 0 11	Progressive
T4	Condition 38 57	clinical conditions
T6	Condition 60 76	Hypersensitivity
T7	Condition 88 95	allergy
T8	Drug 104 125	component of vaccines
T9	Drug 127 145	medicinal products
T10	Device 149 166	medical equipment
T11	Qualifier 167 202	whose use is foreseen in this study
T14	Condition 240 256	contraindication
T15	Procedure 260 285	intramuscular vaccination
T16	Procedure 290 301	blood draws
T18	Non-representable 304 324	Clinical conditions.
T19	Qualifier 326 349	Systemic administration
T20	Drug 353 368	corticosteroids
T21	Qualifier 370 372	PO
T22	Qualifier 373 375	IV
T23	Qualifier 376 378	IM
T25	Temporal 380 420	within 90 days prior to informed consent
T26	Reference_point 404 420	informed consent
T27	Drug 460 483	immunomodulating agents
T28	Drug 441 455;477 483	antineoplastic agents
T29	Procedure 487 499	radiotherapy
T30	Temporal 500 540	within 90 days prior to informed consent
T31	Reference_point 524 540	informed consent
T33	Drug 552 567	immunoglobulins
T34	Drug 575 589	blood products
T35	Temporal 590 631	within 180 days prior to informed consent
T36	Reference_point 615 631	informed consent
T38	Qualifier 646 661	investigational
T39	Qualifier 665 679	non-registered
T40	Drug 680 697	medicinal product
T41	Temporal 698 738	within 30 days prior to informed consent
T42	Reference_point 722 738	informed consent
T44	Non-representable 741 888	Any other clinical condition that, in the opinion of the investigator, might pose additional risk to the subject due to participation in the study.
T45	Drug 905 930	meningococcal vaccination
T46	Temporal 894 901	history
T47	Condition 934 947;963 971	meningococcal diseases
T48	Condition 952 971	gonorrhoea diseases
T50	Procedure 1012 1026	blood donation
T51	Non-representable 974 1011	Enrolment in any activity requiring a
T52	Multiplier 1027 1045	greater than 50 mL
T53	Temporal 1046 1109	during the period starting 30 days before the first study visit
T54	Reference_point 1073 1109	30 days before the first study visit
T55	Temporal 1143 1179	for the duration of the study period
T56	Reference_point 1163 1179	the study period
T58	Drug 1212 1234	immune-modifying drugs
T59	Temporal 1235 1270	at any time during the study period
T60	Reference_point 1254 1270	the study period
T61	Qualifier 1200 1211	long-acting
T62	Condition 1286 1301	blood disorders
T63	Temporal 1320 1327	history
T64	Observation 1331 1368	difficulty in providing blood samples
T65	Drug 1374 1384	antibiotic
T66	Temporal 1392 1424	7 days prior to blood collection
T67	Reference_point 1408 1424	blood collection
T68	Procedure 1440 1447;1459 1464	donated blood
T69	Value 1448 1455	>450 mL
T70	Temporal 1465 1516	within 60 days prior to any blood collection visits
T71	Reference_point 1489 1516	any blood collection visits
T72	Measurement 1578 1598	lost red blood cells
T73	Value 1537 1544	>200 mL
T74	Multiplier 1554 1560	single
T75	Procedure 1561 1570	apheresis
T76	Procedure 1632 1641	apheresis
T77	Multiplier 1602 1624	more than one occasion
T78	Temporal 1642 1669	within the previous 60 days
T79	Reference_point 1649 1669	the previous 60 days
T80	Temporal 1672 1684	Concurrently
T81	Observation 1685 1701;1710 1724	participating in clinical study
T82	Temporal 1726 1761	at any time during the study period
T83	Reference_point 1745 1761	the study period
T84	Drug 1859 1866	vaccine
T85	Drug 1867 1874	product
T87	Qualifier 1818 1833	investigational
T88	Qualifier 1839 1858	non-investigational
T90	Temporal 1876 1883	Ongoing
T91	Condition 1884 1891	anaemia
T92	Measurement 1908 1919	haemoglobin
T93	Value 1927 1992	below the lower limit of the laboratory-specified reference range
T94	Procedure 2001 2020	finger prick method
T95	Condition 2037 2044	anaemia
T96	Non-representable 2096 2273	and the subject will be referred for appropriate medical management. The subject may participate in this study following therapy and evidence that the anaemia has been resolved.
T97	Condition 2290 2298	reaction
T98	Condition 2302 2318	hypersensitivity
T99	Qualifier 2319 2376	likely to be exacerbated by any component of the vaccines
T100	Drug 2351 2376	component of the vaccines
T102	Condition 2379 2387	Pregnant
T103	Observation 2391 2400	lactating
T104	Person 2401 2407	female
T105	Person 2410 2416	Female
T106	Mood 2417 2444	planning to become pregnant
T107	Mood 2448 2471	planning to discontinue
T108	Observation 2472 2497	contraceptive precautions
T109	Mood 2417 2428	planning to
T110	Observation 2429 2444	become pregnant
T111	Qualifier 2504 2513	confirmed
T112	Mood 2517 2526	suspected
T113	Condition 2527 2544;2565 2574	immunosuppressive condition
T114	Condition 2548 2574	immunodeficiency condition
T115	Temporal 2584 2599	medical history
T116	Procedure 2604 2624	physical examination
T120	Observation 2626 2640	Family history
T121	Condition 2658 2685	hereditary immunodeficiency
T122	Condition 2644 2654;2669 2685	congenital immunodeficiency
T124	Qualifier 2688 2695	Serious
T125	Condition 2696 2711	chronic illness
T126	Condition 2725 2752	chronic alcohol consumption
T127	Condition 2760 2770	drug abuse
T128	Temporal 2714 2721	History
